Capvaxive 0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AA1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,956
Award facts
- Contract value 100% obligated
- $39,955.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,955.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CAPVAXIVE 0.5 ML syringes on January 15, 2026, with an ultimate completion date of January 16, 2026. This award was issued without set-aside designation, indicating open and competitive procurement. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal medical procurement.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical commodities—including specialty medications, vaccines, syringes, and other critical healthcare items—to support military healthcare programs worldwide. The contract supports federal medical institutions including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's established capability to fulfill essential pharmaceutical and medical supply requirements for defense and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1AA1?
SPE2DR26F1AA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1AA1 worth?
The government has obligated $39,956 on SPE2DR26F1AA1.
Is contract SPE2DR26F1AA1 an order under another contract?
Yes. SPE2DR26F1AA1 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AA1 competed?
The extent of competition for SPE2DR26F1AA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award